Praxis' epilepsy pipeline takes center stage after Ulixacaltamide's Phase 3 futility. Key trials for vormatrigine and relutrigine set for 2025. See more on PRAX here.

PrimoChill Praxis WetBench. Full Review: <a href=" Pricing & Availability: <a href=" (Amazon) Confirmed AiO's that work on ...

US-based Praxis Precision has decided not to halt its Phase III trial examining its essential tremor (ET) therapy after an independent review insisted it would likely fail to meet its endpoints.

BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines ... The National Law Review is not a law firm nor is www.NatLawReview.com intended to be a referral service for attorneys ...